Semaglutide can suppress the appetite in higher dosages while helping the patient feel fuller for longer
IV infusion: for higher doses, given over 30 minutes to several hours
To view or add a comment, sign in How to individualize renoprotective therapy in obese patients with chronic kidney disease: a commentary by the Diabesity Working Group of the ERA Open Access Nephrology Dialysis Transplantation, Volume 40, Issue 10, October 2025, Pages 19771988, Published: 13 May 2025 The interrelated pandemics of obesity and type 2 diabetes mellitus (T2DM) are fuelling an increase in the prevalence of chronic kidney disease (CKD), which amplifies the risk of cardiovascular events and may progress to end-stage kidney disease (ESKD)
Wegovy HD delivers a maximum maintenance dose of 7.2 mg once weekly , starting at week 21 and beyond
(Yes, and Heres Why Thats Actually Good) Someone asked me if its normal to feel hungry or have a sweet tooth on GLP-1, and honestly